⚠️ MedHub.pk is currently in a development/testing phase. The site is live, but only a few sample products and short blog entries are available at the moment.

Ristova® 100mg/10ml Injection (Rituximab) – Targeted Therapy (Rx)

43,120.00

Generic Name:

Rituximab

Manufacturer:

Roche Pakistan Ltd

Dosage Form:

Intravenous (IV) Infusion

Strength:

100mg / 10ml

Therapeutic Class:

Monoclonal Antibody / Antineoplastic

Prescription Status:

Rx – Prescription Required

Tags:

– Ristova 100mg Price – Rituximab 100mg Injection
– Roche Cancer Medicine – Non-Hodgkin's Lymphoma
– Mabthera alternative

Ristova® 100mg is a highly specialized biologic therapy containing Rituximab, engineered by Roche. It works by targeting the CD20 antigen on B-cells, triggering the body’s immune system to attack malignant or overactive B-cells.

Cold Chain Assurance: Medhub.pk ensures this medication is sourced strictly from authorized Roche distributors. We utilize validated 2°C to 8°C cold-chain packaging with continuous monitoring to guarantee the structural integrity of the vials upon delivery to your hospital.

Additional information

Reviews

There are no reviews yet.

Be the first to review “Ristova® 100mg/10ml Injection (Rituximab) – Targeted Therapy (Rx)”

Your email address will not be published. Required fields are marked *

Yes, a valid prescription from a licensed oncologist or specialist is mandatory.

This specific SKU contains two (2) 100mg/10ml vials.

Yes, Mabthera and Ristova both contain the active ingredient Rituximab manufactured by Roche.

We highly recommend direct delivery to your hospital or infusion center to maintain the cold chain right up to the point of administration.

We provide DRAP-approved supply chain documentation and verifiable batch numbers with every high-value oncology order.

Medhub utilizes temperature data loggers. If the temperature strays outside 2°C-8°C during transit, we replace the medication
Let's Chat